个人中心| | 帮助
高级检索
当前位置： 首页 > 详情页

Expert consensus on cancer treatment-related lung injury

| 认领 | 导出 | |

文献详情

资源类型：
Pubmed体系：

收录情况： ◇ SCIE

作者：
Lin Xinqing[1] * ; Guo Hui[2] * ; Zhao Wei[3] * ; Li Min[4] * ; Lin Gen[5] * ; Chu Qian[6] * ; Chen Enguo[7] ; Chen Liang'an[2] ; Chen Rui[8] ; Chu Tianqing[9] ; Deng Haiyi[1] ; Deng Yu[1] ; Dong Hangming[10] ; Dong Wen[11] ; Dong Yuchao[12] ; Fang Wenfeng[13] ; Gan Xin[14] ; Gong Liang[15] ; Gu Yingying[1] ; Han Qian[1] ; Hao Yue[16] ; He Yong[17] ; Hu Chengping[18] ; Hu Jie[19] ; Hu Yi[20] ; Jiang Yongliang[21] ; Jin Yang[22] ; Lan Fen[23] ; Li Weimin[24] ; Li Weifeng[25] ; Liang Wenhua[1] ; Liu Anwen[26] ; Liu Dan[27] ; Liu Ming[1] ; Liu Mengjie[28] ; Liu Zhuo[29] ; Liu Zhefeng[30] ; Luo Qun[1] ; Miao Liyun[31] ; Mu Chuanyong[32] ; Pan Pinhua[33] ; Peng Ping[34] ; Qin Jianwen[35] ; Qin Yinyin[1] ; Shen Panxiao[1] ; Shi Minhua[36] ; Song Yong[37] ; Su Chunxia[38] ; Su Jin[39] ; Su Xin[31] ; Tan Xiaowu[40] ; Tang Kejing[41] ; Tang Xiaomei[42] ; Tian Panwen[43] ; Wang Binchao[44] ; Wang Huijuan[45] ; Wang Kai[23] ; Wang Mengzhao[46] ; Wang Qi[47] ; Wang Wenxian[48] ; Wang Zhijie[49] ; Wu Di[50] ; Xu Fei[51] ; Xu Yan[46] ; Xu Chunwei[52] ; Xie Zhanhong[1] ; Xie Xiaohong[1] ; Yang Boyan[53] ; Yang Meng[54] ; Ye Feng[55] ; Ye Xiaoqun[56] ; Yu Zongyang[57] ; Zhang Jian[58] ; Zhang Jianqing[59] ; Zhang Xiaoju[60] ; Zhao Fei[61] ; Zheng Xiaobin[62] ; Zhu Bo[63] ; Zhu Zhengfei[64] ; Zhou Jianya[65] ; Zhou Jianying[66] ; Zhou Min[67] ; Zhou Qing[68] ; Zou Zihua[62] ; Kidane Biniam[69] ; Bignami Elena[70] ; Sakamaki Fumio[71] ; Roviello Giandomenico[72] ; Taniguchi Hirokazu[73] ; Jeon Kyeongman[74] ; Saric Lenko[75,76,77] ; Ariza-Prota Miguel[78] ; La-Beck Ninh M[79] ; Kanaji Nobuhiro[80] ; Watanabe Satoshi[81] ; Shukuya Takehito[82] ; Akaba Tomohiro[83] ; Leong Tracy L[84] ; Gesierich Wolfgang[85] ; Koga Yasuhiko[86] ; Tanino Yoshinori[87] ; Uehara Yuji[88,89] ; Li Shiyue[1] ; Chen Rongchang[90,91] ; Zhou Chengzhi[1] ;
机构： [1]State Key Laboratory of Respiratory Disease, National Clinical Research Centre for Respiratory Disease, Guangzhou Institute of Respiratory Health, First Affiliated Hospital, Guangzhou Medical University, Guangzhou, China. [2]Department of Medical Oncology, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China. [3]Department of Respiratory and Critical Care Medicine, Chinese People's Liberation Army (PLA) General Hospital, Beijing, China. [4]Department of Respiratory Medicine, Xiangya Cancer Center, Xiangya Hospital, Central South University, Changsha, China. [5]Department of Medical Oncology, Beijing Chest Hospital, Capital Medical University, Beijing, China. [6]Department of Oncology, Tongji Hospital, Huazhong University of Science and Technology, Wuhan, China. [7]Department of Pulmonary and Critical Care Medicine, Sir Run Run Shaw Hospital of Zhejiang University, Hangzhou, China. [8]Department of Medical Oncology, Sun Yat-sen University Cancer Center, Guangzhou, China. [9]Department of Respiratory Medicine, Shanghai Chest Hospital, Shanghai Jiao Tong University, Shanghai, China. [10]Chronic Airways Diseases Laboratory, Department of Respiratory and Critical Care Medicine, Nanfang Hospital, Southern Medical University, Guangzhou, China. [11]Department of Lung Cancer, Tianjin Lung Cancer Center, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin's Clinical Research Center for Cancer, Tianjin, China. [12]Department of Pulmonary and Critical Care Medicine, Shanghai Changhai Hospital, Second Military Medical University, Shanghai, China. [13]Department of Medical Oncology, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, China. [14]Department of Respiration, The First Affiliated Hospital of Nanchang University, Nanchang, China. [15]Department of Respiratory and Critical Care Medicine, The First Affiliated Hospital of the Army Medical University, Chongqing, China. [16]Department of Clinical Trial, Chinese Academy of Sciences University Cancer Hospital (Zhejiang Cancer Hospital), Hangzhou, China. [17]Department of Pulmonary and Critical Care Medicine, Daping Hospital, Army Medical University, Chongqing, China. [18]Department of Pulmonary Medicine, Xiangya Hospital, Central South University, Changsha, China. [19]Department of Respiratory Medicine, Zhongshan Hospital, Fudan University, Shanghai, China. [20]Department of Medical Oncology, Chinese People's Liberation Army (PLA) General Hospital, Beijing, China. [21]Department of Respiratory Medicine, Hunan Provincial People's Hospital, The First Affiliated Hospital of Hunan Normal University, Changsha, China. [22]Department of Respiratory and Critical Care Medicine, NHC Key Laboratory of Pulmonary Diseases, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China. [23]Department of Respiratory Medicine, The Second Affiliated Hospital of Zhejiang University of Medicine, Hangzhou, China. [24]Department of Respiratory and Critical Care Medicine, Clinical Research Center for Respiratory Disease, West China Hospital, Sichuan University, Chengdu, China. [25]Department of Respiratory Medicine, General Hospital of Guangzhou Military Command of PLA, Guangzhou, China. [26]Department of Oncology, The Second Affiliated Hospital of Nanchang University, Nanchang, China. [27]Department of Respiratory and Critical Care Medicine, West China Hospital, Sichuan University, Chengdu, China. [28]Phase I Clinical Trial Research Ward, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China. [29]Department of Respiratory and Critical Care Medicine, The First Affiliated Hospital of Dalian Medical University, Dalian, China. [30]Department of Oncology, General Hospital of Chinese PLA, Beijing, China. [31]Department of Respiratory and Critical Care Medicine, Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, Nanjing, China. [32]Department of Respiratory Medicine, The First Affiliated Hospital of Soochow University, Suzhou, China. [33]Department of Respiratory Medicine, National Key Clinical Specialty, Branch of National Clinical Research Center for Respiratory Disease, Xiangya Hospital, Central South University, Changsha, China. [34]Cancer Center, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China. [35]Department of Respiratory and Critical Care Medicine, Tianjin Chest Hospital, Tianjin, China. [36]Department of Respiratory Medicine, The Second Affiliated Hospital of Suzhou University, Suzhou, China. [37]Department of Respiratory and Critical Care Medicine, Jinling Hospital, Nanjing, China. [38]Department of Medical Oncology, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai, China. [39]Department of Respiratory and Critical Care Medicine, Nanfang Hospital, Southern Medical University, Guangzhou, China. [40]Pulmonary and Critical Care Medicine, the Second Affiliated Hospital, Hengyang Medical School, University of South China, Hengyang, China. [41]Division of Pulmonary and Critical Care Medicine, The First Affiliated Hospital of Sun Yat-sen University, Institute of Pulmonary Diseases, Sun Yat-sen University, Guangzhou, China. [42]Department of Oncology, Jiangxi Provincial Chest Hospital, Nanchang, China. [43]Lung Cancer Center/Lung Cancer Institute, West China Hospital, Sichuan University, Chengdu, China. [44]Guangdong Lung Cancer Institute, Guangdong General Hospital &amp [45] Guangdong Academy of Medical Sciences, Guangzhou, China. [45]Department of Medical Oncology, The Affiliated Cancer Hospital of Zhengzhou University, Henan Cancer Hospital, Zhengzhou, China. [46]Department of Respiratory and Critical Care Medicine, Peking Union Medical College Hospital, Beijing, China. [47]Department of Respiratory Medicine, The Second Affiliated Hospital of Dalian Medical University, Dalian, China. [48]Department of Chemotherapy, Chinese Academy of Sciences University Cancer Hospital (Zhejiang Cancer Hospital), Hangzhou, China. [49]Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China. [50]Department of Respiratory Medicine, Shenzhen People's Hospital, Shenzhen, China. [51]Department of Respiratory Medicine, The First Affiliated Hospital of Nanchang University, Nanchang, China. [52]Hangzhou Institute of Medicine (HIM), Chinese Academy of Sciences, Hangzhou, China. [53]Department of Comprehensive Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital &amp [55] Shenzhen Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Shenzhen, China. [54]Department of Respiratory Disease, China-Japan Friendship Hospital, Beijing, China. [55]Department of Medical Oncology, Xiamen Key Laboratory of Antitumor Drug Transformation Research, the First Affiliated Hospital of Xiamen University, School of Medicine, Xiamen University, Xiamen, China. [56]Department of Respiratory Diseases, The Second Affiliated Hospital of Nanchang University, Nanchang, China. [57]Department of Pulmonary and Critical Care Medicine, The 900th Hospital of Joint Logistic Support Force, PLA, Fuzhou, China. [58]Department of Pulmonary and Critical Care Medicine, Xijing Hospital, Fourth Military Medical University, Xi'an, China. [59]Second Department of Respiratory and Critical Care Medicine, First Affiliated Hospital of Kunming Medical University, Kunming, China. [60]Department of Respiratory and Critical Care Medicine, Henan Provincial People's Hospital, People's Hospital of Zhengzhou University, Zhengzhou, China. [61]Department of Respiratory and Critical Care Medicine, Changsha Hospital of Traditional Chinese Medicine (Changsha Eighth Hospital), Changsha, China. [62]Department of Thoracic Oncology, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou, China. [63]Chongqing Key Laboratory of Immunotherapy, Xinqiao Hospital, Third Military Medical University, Chongqing, China. [64]Department of Radiation Oncology, Fudan University Shanghai Cancer Center, Shanghai, China. [65]Department of Respiratory Disease, Thoracic Disease Center, The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, China. [66]Department of Respiratory Diseases, The First Affiliated Hospital of College of Medicine, Zhejiang University, Hangzhou, China. [67]Department of Pulmonary and Critical Care Medicine, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China. [68]Guangdong Lung Cancer Institute, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou, China. [69]Section of Thoracic Surgery, Department of Surgery and Department of Physiology &amp [72] Pathophysiology University of Manitoba, Winnipeg, Canada. [70]Anesthesiology, Critical Care and Pain Medicine Division, Department of Medicine and Surgery, University of Parma, Parma, Italy. [71]Department of Respiratory Medicine, Tokai University Hachioji Hospital, Tokai University School of Medicine, Tokyo, Japan. [72]Department of Health Sciences, University of Florence, Florence, Italy. [73]Clinical Oncology Center, Nagasaki University Hospital, Nagasaki, Japan. [74]Division of Pulmonary and Critical Care Medicine, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea. [75]Department of Anesthesiology, Reanimatology and Intensive Care, University Hospital Split, Split, Croatia. [76]University Department of Health Studies, University of Split, Split, Croatia. [77]Medical School, University of Split, Split, Croatia. [78]Division of Respiratory Medicine, Interventional Pulmonology Unit, Hospital Universitario Central de Asturias, Oviedo, Spain. [79]Department of Immunotherapeutics and Biotechnology, Jerry H. Hodge School of Pharmacy, Texas Tech University Health Sciences Center, Abilene, TX, USA. [80]Division of Hematology, Rheumatology and Respiratory Medicine, Department of Internal Medicine, Faculty of Medicine, Kagawa University, Kagawa, Japan. [81]Department of Respiratory Medicine and Infectious Diseases, Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan. [82]Department of Respiratory Medicine, Juntendo University Graduate School of Medicine, Tokyo, Japan. [83]Department of Respiratory Medicine, Tokyo Women's Medical University, Tokyo, Japan. [84]Department of Respiratory Medicine, Austin Hospital, Heidelberg, Victoria, Australia. [85]Department of Pulmonology, Asklepios Lung Clinic Gauting, Center for Respiratory Medicine and Thoracic Surgery, Gauting, Germany. [86]Department of Respiratory Medicine, Gunma University Graduate School of Medicine, Maebashi, Japan. [87]Department of Pulmonary Medicine, Fukushima Medical University School of Medicine, Fukushima, Japan. [88]Department of Thoracic Oncology and Respiratory Medicine, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Tokyo, Japan. [89]Division of Cancer Evolution, National Cancer Center Japan Research Institute, Tokyo, Japan. [90]Shenzhen Institute of Respiratory Diseases, Shenzhen People's Hospital, Shenzhen, China. [91]Guangzhou Institute of Respiratory Health, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.
出处：
DOI： 10.21037/jtd-2025-292
ISSN：

关键词： Cancer anti-tumor therapy lung injury diagnosis treatment

摘要：
Although advancements in cancer therapies have substantially improved the survival of cancer patients, these treatments may also result in acute or chronic lung injury. Cancer treatment-related lung injury (CTLI) presents with a diverse array of clinical manifestations and can involve multiple sites. Due to the lack of specific diagnostic protocols, CTLI can deteriorate rapidly and may be life-threatening if not promptly addressed. Unfortunately, there is no universally accepted consensus document on the diagnosis and management of CTLI.A multidisciplinary panel comprising experts from respiratory and critical care medicine, oncology, radiation oncology, thoracic surgery, radiology, pathology, infectious diseases, pharmacy, and rehabilitation medicine participated in this consensus development. Through a systematic literature review and detailed panel discussions, the team formulated nine key recommendations.This consensus document addresses the concept, epidemiology, pathogenesis, risk factors, diagnostic approach, evaluation workflow, management strategies, differential diagnosis, type-specific management and clinical staging of CTLI. Emphasis is placed on raising awareness among clinicians and therapeutic practices through comprehensive guidelines.The consensus provides a detailed diagnostic protocol for CTLI and introduces a structured management framework based on grading, typing, and staging. It highlights the critical role of multidisciplinary team (MDT) collaboration and emphasizes the need for individualized, whole-process patient care strategies to optimize clinical outcomes.Copyright © 2025 AME Publishing Company. All rights reserved.

语种：
外文
被引次数：
PubmedID：
中科院(CAS)分区：
出版当年[2025]版：
大类 | 4 区 医学
小类 | 4 区 呼吸系统
最新[2025]版：
大类 | 4 区 医学
小类 | 4 区 呼吸系统
JCR分区：
出版当年[2024]版：
Q3 RESPIRATORY SYSTEM
最新[2024]版：
Q3 RESPIRATORY SYSTEM

影响因子： 最新[2024版] 最新五年平均 出版当年[2024版] 出版当年五年平均 出版前一年[2024版]

第一作者：
第一作者机构： [1]State Key Laboratory of Respiratory Disease, National Clinical Research Centre for Respiratory Disease, Guangzhou Institute of Respiratory Health, First Affiliated Hospital, Guangzhou Medical University, Guangzhou, China.
共同第一作者：
通讯作者：
通讯机构： [90]Shenzhen Institute of Respiratory Diseases, Shenzhen People's Hospital, Shenzhen, China. [91]Guangzhou Institute of Respiratory Health, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.
推荐引用方式(GB/T 7714)：
Lin Xinqing,Guo Hui,Zhao Wei,et al.Expert consensus on cancer treatment-related lung injury[J].Journal Of Thoracic Disease.2025,17(4):1844-1875.doi:10.21037/jtd-2025-292.
APA：
Lin Xinqing,Guo Hui,Zhao Wei,Li Min,Lin Gen...&Zhou Chengzhi.(2025).Expert consensus on cancer treatment-related lung injury.Journal Of Thoracic Disease,17,(4)
MLA：
Lin Xinqing,et al."Expert consensus on cancer treatment-related lung injury".Journal Of Thoracic Disease 17..4(2025):1844-1875

相关文献

[1]Tumor angiogenesis and anti-angiogenic therapy [2]Preparation of Photodynamic Therapy Tablet and Method for Construction and Application of Anti-Tumor Model for Enhanced Cancer Treatment [3]Necroptosis in tumorigenesis, activation of anti-tumor immunity, and cancer therapy. [4]Tumor-infiltrating lymphocytes predict prognosis of breast cancer patients treated with anti-Her-2 therapy [5]Multi-omic analyses of changes in the tumor microenvironment of pancreatic adenocarcinoma following neoadjuvant treatment with anti-PD-1 therapy [6]Platelet-Based Nanoparticles with Stimuli-Responsive for Anti-Tumor Therapy [7]Multiple Treatment of Triple-Negative Breast Cancer Through Gambogic Acid-Loaded Mesoporous Polydopamine [8]放射治疗联合抗肿瘤血管治疗研究进展 [9]Relationship between exosomes and cancer: formation, diagnosis, and treatment [10]Role of Gold Nanorods Functionalized by Nucleic Acid Nanostructures Carrying Doxorubicin in Synergistic Anti-Cancer Therapy

资源点击量：65780 今日访问量：3 总访问量：5151 更新日期：2025-12-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 四川省肿瘤医院 技术支持：重庆聚合科技有限公司 地址：成都市人民南路四段55号